Bonk (SHOT) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
14 Aug, 2026Executive summary
Revenue for the six months ended June 30, 2026 was $5.5M, driven by beverage sales and related party digital asset revenue share, up significantly from $87K in the prior year period due to the Yerbaé acquisition and digital asset initiatives.
Net loss for the six months ended June 30, 2026 was $7.9M, compared to net income of $8.0M in the prior year period, reflecting higher operating expenses and significant unrealized losses on digital assets.
The company completed the acquisition of Yerbaé, expanding its beverage portfolio, and continued to implement a digital asset strategy centered on the BONK ecosystem.
Financial highlights
Revenue: $1.58M from beverage sales and $3.92M from related party digital asset revenue share for the six months ended June 30, 2026.
Gross profit for the six months was $62.9K, with cost of sales at $1.52M.
Operating expenses for the six months were $4.65M, down from $9.77M in the prior year period.
Other income/expense included a $796K gain on sale of marketable securities and an $8.17M unrealized loss on digital assets.
Net loss per share for the six months was $(0.99), compared to $1.97 EPS in the prior year period.
Outlook and guidance
Management highlights substantial doubt about the company's ability to continue as a going concern due to recurring losses, negative cash flows, and low cash balances.
The company expects to continue incurring significant costs as it pursues expansion and development plans.
Latest events from Bonk
- Revenue surged in Q1 2026, but liquidity and regulatory risks remain significant.SHOT
Q1 2026 - Shelf registration enables up to $100M in securities sales as company pivots to digital assets.SHOT
Registration filing - 2025 revenue grew to $3.93M, but net loss deepened to $68.2M amid digital asset volatility.SHOT
Q4 2025 - Amended registration for public stock offering, led by CEO Jarrett Boon, with $113K in expenses.SHOT
Registration Filing - Patented dietary supplement business registers shares for resale, funding R&D and growth.SHOT
Registration Filing - Registering 1.9M shares for resale; proceeds from warrants fund R&D and working capital.SHOT
Registration Filing - Patented dietary supplement targets alcohol metabolism, with shares registered for resale on NASDAQ.SHOT
Registration Filing - Registering 1.9M shares for resale, with proceeds from options and warrants funding R&D.SHOT
Registration Filing - Registers 31.8M shares for resale after a strategic pivot to digital assets and DeFi.SHOT
Registration Filing